Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer.

Pancreas - 1 Oct 2020

Wu Yixing, Huang Huatian, Fervers Beatrice, Lu Lingeng

Abstract excerpt

OBJECTIVES: The purpose of this study was to investigate the association of syndecan-1 (SDC1) and KRAS molecular characteristics with patient survival in pancreatic cancer. METHODS: Both SDC1 mRNA and methylation and KRAS mRNA and somatic mutations, as well as clinical data were retrieved from The Cancer Genome Alta pancreatic cancer data set for survival analyses. Kyoto Encyclopedia of Gene and Genomes pathway...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Gene Expression Profiling
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Pancreatic Neoplasms

Share to Proportional Hazards Models

Share to Proto-Oncogene Proteins p21(ras)

Share to Syndecan-1

Source

Identifiers

PMID: 32898003
DOI: 10.1097/MPA.0000000000001654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer.PMID 32898003Read ↗

Pancreatic cancer survival analysis defines a signature that predicts outcomeSemantic proximity Read ↗

Three hypomethylated genes were associated with poor overall survival in pancreatic cancer patientsSemantic proximity Read ↗

Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma.Semantic proximity Read ↗

Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human CancerSemantic proximity Read ↗

Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and TherapySemantic proximity Read ↗

SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-αSemantic proximity Read ↗

Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.Semantic proximity Read ↗

Genome-scale activation screen reveals lncRNA HNF1A-AS1 as a novel therapeutic target for pancreatic cancer metastasisSemantic proximity Read ↗

N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathwaySemantic proximity Read ↗

Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.